Assessing the quality of CKD care using process quality indicators: A scoping review.

Na Zhou, Aminu K Bello, Yanhua Chen, Ping Liu, Chengchuan Chen, Yubei Liu, Zhaolan Yu

Journal: PloS one 2024;19(12):e0309973

PMID: 39656690

Abstract

INTRODUCTION

Assessing the quality of chronic kidney disease (CKD) management is crucial for optimal care and identifying care gaps. It is largely unknown which quality indicators have been widely used and the potential variations in the quality of CKD care. We sought to summarize process quality indicators for CKD and assess the quality of CKD care.

METHODS

We searched databases including Medline (Ovid), PubMed, Cochrane Library, Web of Science, CINAHL, and Scopus from inception to June 20, 2024. Two reviewers screened the identified records, extracted relevant data, and classified categories and themes of quality indicators.

RESULTS

We included 24 studies, extracted 30 quality indicators, and classified them into three categories with nine themes. The three categories included laboratory measures and monitoring of CKD progression and/or complications (monitoring of kidney markers, CKD mineral and bone disorder, anemia and malnutrition, electrolytes, and volume), use of guideline-recommended therapeutic agents (use of medications), and attainment of therapeutic targets (blood pressure, glycemia, and lipids). Among the frequently reported quality indicators (in five or more studies), the following have a median proportion of study participants achieving that quality indicator exceeding 50%: monitoring of kidney markers (Scr/eGFR), use of medications (ACEIs/ARBs, avoiding non-steroidal anti-inflammatory drugs (NSAIDs)), management of blood pressure (with a target of ≤140/90, or without specific targets), and monitoring for glycated hemoglobin A1c (HbA1c)). The presence of diabetes, hypertension, cardiovascular disease, or proteinuria was associated with higher achievement in indicators of monitoring of kidney markers, use of recommended medications, and management of blood pressure and glycemia.

CONCLUSION

The quality of CKD management varies with quality indicators. A more consistent and complete reporting of key quality indicators is needed for future studies assessing CKD care quality.

Copyright: © 2024 Zhou et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Address: School of Nursing, Southwest Medical University, Luzhou, Sichuan Province, China.; Department of Cardiology, The First Affiliated Hospital, Chengdu Medical College, Chengdu, Sichuan Province, China.; Department of Anesthesiology, Chengdu Qingbaijiang District Traditional Chinese Medicine Hospital, Chengdu, Sichuan Province, China.; School of Nursing, Southwest Medical University, Luzhou, Sichuan Province, China.; Department of Nephrology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China.; Faculty of Medicine and Dentistry, Division of Nephrology and Immunology, University of Alberta, Edmonton, Alberta, Canada.; School of Nursing, Southwest Medical University, Luzhou, Sichuan Province, China.; Department of Nursing, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China.; School of Nursing, Southwest Medical University, Luzhou, Sichuan Province, China.; Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.